Gewählte Publikation:
Dettke, M; Jurko, S; Rüger, BM; Leitner, G; Greinix, HT; Kalhs, P; Fischer, MB; Höcker, P.
Increased serum flt3-ligand in healthy donors undergoing granulocyte colony-stimulating factor-induced peripheral stem cell mobilization.
J Hematother Stem Cell Res. 2001; 10(2):317-320
Doi: 10.1089/15258160151135105
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
-
Greinix Hildegard
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
The effect of granulocyte colony-stimulating factor (G-CSF) induced mobilization of peripheral blood progenitor cells (PBPC) on the endogenous serum levels of cytokines stem cell factor (SCF) and flt3-ligand (flt3-L) was studied in 18 healthy subjects undergoing allogeneic PBPC donation. Donors received a standardized mobilization regime consisting of a 4-day course of G-CSF, with leukapheresis on day 5. Endogenous serum flt3-L and SCF were determined prior to G-CSF administration, on the day of leukapheresis, and followed up until day +100 after cessation of G-CSF administration. The administration of G-CSF resulted in a transient elevation of endogenous flt3-L serum levels. At the day of leukapheresis serum flt3-L showed a median increase of 75% compared to serum flt3-L levels obtained before G-CSF treatment. The increase in serum flt3-L levels showed no correlation with the total number of progenitor cells mobilized. Cessation of G-CSF treatment led to normalization of serum flt3-L within 7 days post G-CSF administration. In contrast, serum CSF levels remained unchanged in response to G-CSF administration. Our results demonstrate a transient surge in serum flt3-L in relation to G-CSF-induced PBPC mobilization, although the assessment of endogenous flt3-L give no information regarding the ability for G-CSF-induced PBPC recruitment in healthy individuals.
- Find related publications in this database (using NLM MeSH Indexing)
-
Adolescent -
-
Adult -
-
Female -
-
Granulocyte Colony-Stimulating Factor - therapeutic use
-
Hematopoiesis -
-
Hematopoietic Stem Cell Mobilization - methods
-
Humans -
-
Leukapheresis -
-
Living Donors -
-
Male -
-
Membrane Proteins - blood
-
Middle Aged -
-
Recombinant Proteins -
-
Stem Cell Factor - blood
-
Time Factors -